An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment
- 1 August 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 886, 173457
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaNew England Journal of Medicine, 2014
- Reactive Oxygen Species in Inflammation and Tissue InjuryAntioxidants & Redox Signaling, 2014
- Physiology and Pathophysiology of CarnosinePhysiological Reviews, 2013
- Nitric oxide and oxidative stress in vascular diseasePflügers Archiv - European Journal of Physiology, 2010
- The Role of Nitric Oxide in Myocardial Repair and RemodelingAntioxidants & Redox Signaling, 2009
- Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cellsExperimental Eye Research, 2007
- Full survival of paraquat-exposed rats after treatment with sodium salicylate☆Free Radical Biology and Medicine, 2007
- An Overview of Acetic Acid Ulcer Models—The History and State of the Art of Peptic Ulcer Research—2005
- Low-dose aspirin and stroke.Stroke, 1993
- Clinical Pharmacokinetics of the SalicylatesClinical Pharmacokinetics, 1985